Thermostable Formulations of a Hepatitis B Vaccine and a Meningitis A Polysaccharide Conjugate Vaccine Produced by a Spray-Drying Method
This article, published in the journal Vaccine, reports that employing a spray-drying process to produce glassy state formulations of two common subunit vaccines demonstrates that the production of thermostable vaccines is achievable. The process was tested on recombinant hepatitis B vaccine containing aluminum adjuvant and meningitis A protein-polysaccharide conjugate vaccine. The spray-dried hepatitis B formulations remained stable for at least 24 months at 37°C, and several of the meningitis A formulations were completely stable at temperatures up to 60°C for at least 2 weeks, which is when the test ended. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Chen D, Kapre S, Goel A, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Chen D, Kapre S, Goel A, et al. Thermostable Formulations of a Hepatitis B Vaccine and a Meningitis A Polysaccharide Conjugate Vaccine Produced by a Spray-Drying Method. Vaccine. 2010;28(31):5093-9.
Resource types: Peer-reviewed journal